methocarbamol has been researched along with Liver Cirrhosis in 1 studies
Methocarbamol: A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)
methocarbamol : A racemate comprising equimolar amounts of (R)- and (S)-methocarbamol. A centrally acting skeletal muscle relaxant, it is used as an adjunct in the short-term symptomatic treatment of painful muscle spasm. The (R)-enantiomer is more active than the (S)-enantiomer.
2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate : A carbamate ester that is glycerol in which one of the primary alcohol groups has been converted to its 2-methoxyphenyl ether while the other has been converted to the corresponding carbamate ester.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients who were treated with methocarbamol showed a significant decrease in the frequency and duration of cramps." | 9.30 | Randomized-controlled trial of methocarbamol as a novel treatment for muscle cramps in cirrhotic patients. ( Abd-Elsalam, S; Arafa, M; Badawi, R; Elfert, A; Elkadeem, M; Elkhalawany, W; Soliman, S, 2019) |
| "Patients who were treated with methocarbamol showed a significant decrease in the frequency and duration of cramps." | 5.30 | Randomized-controlled trial of methocarbamol as a novel treatment for muscle cramps in cirrhotic patients. ( Abd-Elsalam, S; Arafa, M; Badawi, R; Elfert, A; Elkadeem, M; Elkhalawany, W; Soliman, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Elsalam, S | 1 |
| Arafa, M | 1 |
| Elkadeem, M | 1 |
| Elfert, A | 1 |
| Soliman, S | 1 |
| Elkhalawany, W | 1 |
| Badawi, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis[NCT05724485] | Phase 4 | 50 participants (Anticipated) | Interventional | 2023-04-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for methocarbamol and Liver Cirrhosis
| Article | Year |
|---|---|
Randomized-controlled trial of methocarbamol as a novel treatment for muscle cramps in cirrhotic patients.
Topics: Adult; Aged; Double-Blind Method; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Metho | 2019 |